Applied Genetic Technologies reported 667K in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alimera Sciences ALIM:US $ 1.36M 0M
Applied Genetic Technologies AGTC:US 667K 8K
Avrobio Inc AVRO:US 304K 101K
Biogen BIIB:US $ 66.1M 0.2M
Cti Biopharma CTIC:US $ 2.08M 0.66M
Gilead Sciences GILD:US $ 238M 0M
Insmed INSM:US $ 3.29M 8.06M
Intercept Pharmaceuticals ICPT:US $ 6.67M 8.64M
Regeneron Pharmaceuticals REGN:US $ 13.6M 0.5M
Rigel Pharmaceuticals RIGL:US $ 1.2M 0.09M